Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Expres2ion UpdateS On Expectations To COVID-19 Vaccine Program

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    19/08/2020 14:47
    Aug 19 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION PROVIDES UPDATE ON ITS EXPECTATIONS TO THE
COVID-19
VACCINE PROGRAM PRIOR TO THE Q2 2020 REPORT
    * EXPRES2ION BIOTECH HOLDING AB - NOW EXPECTS PHASE III
TRIALS TO
COMMENCE AS SOON AS FIRST HALF OF 2021, WITH POSSIBLE MARKET
LAUNCH BEFORE END OF 2021

Source text for Eikon:  ID:nWkrb8GBzd 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news